Physician profile
Yulin Wang
NPI 1629201942
$1,478.78
in general payments reported to CMS, 2019-2025
12 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.08 · 2023: $242 · 2024: $113 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $323.89 | 2024-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Amgen INC. | $207.29 | 2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $145.83 | 2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $143.62 | 2025 | Mounjaro, Zepbound |
| Alexion Pharmaceuticals, INC. | $130.05 | 2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2023 | Breztri |
| Regeneron Healthcare Solutions, INC. | $124.90 | 2025 | Dupixent |
| Foundation Medicine, INC. | $116.67 | 2023 | |
| Genzyme Corporation | $95.26 | 2024 | |
| Phathom Pharmaceuticals, INC. | $24.22 | 2025 | Voquezna |
| Sun Pharmaceutical Industries INC. | $24.08 | 2022 | |
| Exact Sciences Corporation | $17.97 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yulin Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.